These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 24821568

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
    Shobugawa Y, Saito R, Sato I, Kawashima T, Dapat C, Dapat IC, Kondo H, Suzuki Y, Saito K, Suzuki H.
    J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
    [Abstract] [Full Text] [Related]

  • 3. Clinical effectiveness of four neuraminidase inhibitors (oseltamivir, zanamivir, laninamivir, and peramivir) for children with influenza A and B in the 2014-2015 to 2016-2017 influenza seasons in Japan.
    Ishiguro N, Koseki N, Kaiho M, Ariga T, Kikuta H, Oba K, Togashi T, Morita K, Inagawa A, Okamura A, Yamazaki S, Shida S, Konno M, Kawamura N, Ishizaka A, Takada K, Tsubakihara K, Nagano N, Shibata M, Furuyama H, Matsuzono Y, Koike A, Murashita M, Hatae Y, Arioka H, Yamanaka T, Watanabe T, Tabata Y, Kumita Y, Hazama K, Akutsu Y, Aoyagi H, Tobise C, Azuma K, Yasoshima K, Sawada Y, Uetsuji K, Tsuchida A, Tsuchiyama A, Yasuda K, Odagawa Y, Yoshioka M.
    J Infect Chemother; 2018 Jun; 24(6):449-457. PubMed ID: 29487035
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Emergence of Multidrug-Resistant Influenza A(H1N1)pdm09 Virus Variants in an Immunocompromised Child Treated With Oseltamivir and Zanamivir.
    Tamura D, DeBiasi RL, Okomo-Adhiambo M, Mishin VP, Campbell AP, Loechelt B, Wiedermann BL, Fry AM, Gubareva LV.
    J Infect Dis; 2015 Oct 15; 212(8):1209-13. PubMed ID: 25943200
    [Abstract] [Full Text] [Related]

  • 10. Trends of neuraminidase inhibitors use in children with influenza related respiratory infections.
    Uda K, Okubo Y, Shoji K, Miyairi I, Morisaki N, Michihata N, Matsui H, Fushimi K, Yasunaga H.
    Pediatr Pulmonol; 2018 Jun 15; 53(6):802-808. PubMed ID: 29673121
    [Abstract] [Full Text] [Related]

  • 11. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japanese 2013-2014 season.
    Ikematsu H, Kawai N, Iwaki N, Kashiwagi S.
    J Infect Chemother; 2015 Sep 15; 21(9):634-8. PubMed ID: 26096495
    [Abstract] [Full Text] [Related]

  • 12. In vitro neuraminidase inhibitory activities of four neuraminidase inhibitors against influenza viruses isolated in the 2010-2011 season in Japan.
    Ikematsu H, Kawai N, Kashiwagi S.
    J Infect Chemother; 2012 Aug 15; 18(4):529-33. PubMed ID: 22370919
    [Abstract] [Full Text] [Related]

  • 13. The effect of neuraminidase inhibitors on household transmission in Japanese patients with influenza A and B infection: A prospective, observational study.
    Hirotsu N, Saisho Y, Hasegawa T.
    Influenza Other Respir Viruses; 2019 Mar 15; 13(2):123-132. PubMed ID: 29989680
    [Abstract] [Full Text] [Related]

  • 14. Duration of fever in children infected with influenza A(H1N1)pdm09, A(H3N2) or B virus and treated with baloxavir marboxil, oseltamivir, laninamivir, or zanamivir in Japan during the 2012-2013 and 2019-2020 influenza seasons.
    Sun Y, Wagatsuma K, Saito R, Sato I, Kawashima T, Saito T, Shimada Y, Ono Y, Kakuya F, Minato M, Kodo N, Suzuki E, Kitano A, Chon I, Phyu WW, Li J, Watanabe H.
    Antiviral Res; 2024 Aug 15; 228():105938. PubMed ID: 38897317
    [Abstract] [Full Text] [Related]

  • 15. Optimizing antiviral therapy for influenza: understanding the evidence.
    Ison MG.
    Expert Rev Anti Infect Ther; 2015 Apr 15; 13(4):417-25. PubMed ID: 25695406
    [Abstract] [Full Text] [Related]

  • 16. Neuraminidase inhibitors for preventing and treating influenza in children (published trials only).
    Wang K, Shun-Shin M, Gill P, Perera R, Harnden A.
    Cochrane Database Syst Rev; 2012 Apr 18; 2012(4):CD002744. PubMed ID: 22513907
    [Abstract] [Full Text] [Related]

  • 17. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013.
    Meijer A, Rebelo-de-Andrade H, Correia V, Besselaar T, Drager-Dayal R, Fry A, Gregory V, Gubareva L, Kageyama T, Lackenby A, Lo J, Odagiri T, Pereyaslov D, Siqueira MM, Takashita E, Tashiro M, Wang D, Wong S, Zhang W, Daniels RS, Hurt AC.
    Antiviral Res; 2014 Oct 18; 110():31-41. PubMed ID: 25043638
    [Abstract] [Full Text] [Related]

  • 18. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012-2013 season.
    Ikematsu H, Kawai N, Iwaki N, Kashiwagi S.
    J Infect Chemother; 2015 Jan 18; 21(1):39-42. PubMed ID: 25277670
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.